NCT05989113

Brief Summary

This is an observational, prospective multicentric study designed to develop medical knowledge. The aim of the study is to validate the IPAQ-SF questionnaire in a population of lower limb amputee patients. The questionnaire is administered twice to each patient, once during the consultation and again when they return home. Patients also undergo a 6-minute walk test.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2023

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2023

Completed
6 days until next milestone

Study Start

First participant enrolled

May 3, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 14, 2023

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

September 1, 2023

Status Verified

April 1, 2023

Enrollment Period

4 months

First QC Date

April 27, 2023

Last Update Submit

August 30, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Correlation of the METs/week questionnaire results with the results of the 6-minute walk test

    The results of the IPAQ-SF questionnaire will be expressed in METs/week (Metabolic Equivalent of Task). The distance covered by the patient at the end of the 6-minute test will be collected in meters.

    Data collection during the routine consultation on the day of inclusion

Secondary Outcomes (9)

  • Relationships between the patients ability to perform his or her expected daily functions after rehabilitation (MFCL classification, out of 5 points) and the IPAQ-SF score.

    Data collection during the routine consultation on the day of inclusion

  • Relationships between the level of amputation and the IPAQ-SF score.

    Data collection during the routine consultation on the day of inclusion

  • Relationships between the patient's weight and the IPAQ-SF score.

    Data collection during the routine consultation on the day of inclusion

  • Relationships between type of prosthesis and the IPAQ-SF score.

    Data collection during the routine consultation on the day of inclusion

  • Relationships between the age of amputation and the IPAQ-SF score.

    Data collection during the routine consultation on the day of inclusion

  • +4 more secondary outcomes

Study Arms (1)

Lower limb amputee patients with devices

Other: Administration of the IPAQ-SF questionnaire

Interventions

Administration of the IPAQ-SF questionnaire at the patient's consultation and upon return home

Lower limb amputee patients with devices

Eligibility Criteria

Age15 Years - 69 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Lower limb amputee patients with devices

You may qualify if:

  • Patients who have undergone a major lower limb amputation: transtibial, transfemoral, hip or knee disarticulation or trans-iliolumbar
  • Fitting more than 1 year old
  • Age 15-69 years (IPAQ-SF not validated outside these ages)
  • All causes of amputation (vascular, traumatic, tumor, infectious...)
  • Patient having given their informed consent
  • Patient affiliated to a social security system

You may not qualify if:

  • Subjects with bilateral amputations
  • Inability to fully and adequately understand the questionnaire (i.e., cognitive impairment, patient does not speak French)
  • Contraindication to the 6-minute walk test (chest pain, palpitations, mental confusion or lack of coordination and balance, dizziness or malaise, intolerable dyspnea, leg cramps or extreme leg muscle fatigue, any other clinically justified reason).
  • Patients under legal protection (under guardianship, under curatorship, safeguard of justice)
  • Pregnant or breast-feeding woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Institut Calvé

Berck, France

RECRUITING

CHRU Lille - Hôpital Swynghedauw

Lille, 59037, France

RECRUITING

CRF les HAUTOIS- CRO

Oignies, 62590, France

RECRUITING

Related Links

Study Officials

  • Frédéric Charlaté

    Fondation Hopale

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2023

First Posted

August 14, 2023

Study Start

May 3, 2023

Primary Completion

September 1, 2023

Study Completion

September 1, 2023

Last Updated

September 1, 2023

Record last verified: 2023-04

Locations